Šalis: Airija
kalba: anglų
Šaltinis: HPRA (Health Products Regulatory Authority)
FUROSEMIDE
Le Vet Beheer B.V.
QC03CA01
FUROSEMIDE
40 mg/tablet
Tablets
POM
Canine, Feline
Furosemide
Cardiovascular
Authorised
2015-02-20
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Furosoral 40 mg tablets for cats and dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains: ACTIVE SUBSTANCE: Furosemide 40 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. White to yellow-white round and convex tablet with a cross-shaped break line on one side. Tablets can be divided into two or four equal parts. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats and dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of hydrothorax, hydropericardium, ascites and oedema, particularly associated with cardiac insufficiency and renal dysfunction. 4.3 CONTRAINDICATIONS Do not use in animals suffering from hypovolaemia, hypotension or dehydration. Do not use in cases of renal failure with anuria. Do not use in cases of electrolyte deficiency. Do not use in cases of known hypersensitivity to furosemide, sulphonamides or any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Therapeutic efficacy may be impaired by increased intake of drinking water. Where the animal’s condition permits, water intake should be restricted to physiologically normal levels during treatment. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 10/03/2015_ _CRN 7019898_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Furosemide should be used with caution in the case of pre-existing electrolyte and/or water imbalance, impaired hepatic function (may precipitate hepatic coma) and diabetes mellitus. In case of prolonged treatment, hydration status and serum electrolytes should be monitored frequently. 1-2 days before and after commenc Perskaitykite visą dokumentą